About this Event
This webinar is designed to equip healthcare teams with essential information on FDA-approved monthly and weekly injectable buprenorphine formulations for the treatment of opioid use disorder, along with guidance on integrating them into clinical practice. Key topics will include the pharmacology, side effects, and storage of injectable buprenorphine, as well as the administration process, patient selection criteria, and dosage recommendations. The session will also cover the initiation and maintenance of treatment for patients using these injectable formulations, along with the workflows and administrative tasks involved in implementing injectable buprenorphine in healthcare settings.
Go to our Event Page to learn more information about this event including any CE credit opportunities.
Event Venue
Online
USD 0.00
